Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Synthesis of C-6 substituted pyrazolo[1,5-a]pyridines with potent activity against herpesviruses.

Allen SH, Johns BA, Gudmundsson KS, Freeman GA, Boyd FL Jr, Sexton CH, Selleseth DW, Creech KL, Moniri KR.

Bioorg Med Chem. 2006 Feb 15;14(4):944-54. Epub 2005 Oct 4.

PMID:
16213142
2.

Antiviral activity of GW678248, a novel benzophenone nonnucleoside reverse transcriptase inhibitor.

Ferris RG, Hazen RJ, Roberts GB, St Clair MH, Chan JH, Romines KR, Freeman GA, Tidwell JH, Schaller LT, Cowan JR, Short SA, Weaver KL, Selleseth DW, Moniri KR, Boone LR.

Antimicrob Agents Chemother. 2005 Oct;49(10):4046-51.

3.

Synthesis of novel substituted 2-phenylpyrazolopyridines with potent activity against herpesviruses.

Gudmundsson KS, Johns BA, Wang Z, Turner EM, Allen SH, Freeman GA, Boyd FL Jr, Sexton CJ, Selleseth DW, Moniri KR, Creech KL.

Bioorg Med Chem. 2005 Sep 15;13(18):5346-61.

PMID:
16039862
4.

Pyrazolopyridine antiherpetics: SAR of C2' and C7 amine substituents.

Johns BA, Gudmundsson KS, Turner EM, Allen SH, Samano VA, Ray JA, Freeman GA, Boyd FL Jr, Sexton CJ, Selleseth DW, Creech KL, Moniri KR.

Bioorg Med Chem. 2005 Apr 1;13(7):2397-411.

PMID:
15755642
5.

Mechanism of action of the ribopyranoside benzimidazole GW275175X against human cytomegalovirus.

Underwood MR, Ferris RG, Selleseth DW, Davis MG, Drach JC, Townsend LB, Biron KK, Boyd FL.

Antimicrob Agents Chemother. 2004 May;48(5):1647-51.

6.

Interactions of 1263W94 with other antiviral agents in inhibition of human cytomegalovirus replication.

Selleseth DW, Talarico CL, Miller T, Lutz MW, Biron KK, Harvey RJ.

Antimicrob Agents Chemother. 2003 Apr;47(4):1468-71.

7.

Benzimidazole 2'-isonucleosides: design, synthesis, and antiviral activity of 2-substituted-5,6-dichlorobenzimidazole 2'-isonucleosides.

Freeman GA, Selleseth DW, Rideout JL, Harvey RJ.

Nucleosides Nucleotides Nucleic Acids. 2000 Jan-Feb;19(1-2):155-74.

PMID:
10772707
8.

Synthesis and evaluation of a series of 2'-deoxy analogues of the antiviral agent 5,6-dichloro-2-isopropylamino-1-(beta-L-ribofuranosyl)-1H-benzimidazole (1263W94).

Chan JH, Chamberlain SD, Biron KK, Davis MG, Harvey RJ, Selleseth DW, Dornsife RE, Dark EH, Frick LW, Townsend LB, Drach JC, Koszalka GW.

Nucleosides Nucleotides Nucleic Acids. 2000 Jan-Feb;19(1-2):101-23. Erratum in: Nucleosides Nucleotides Nucleic Acids. 2002;21(1):109.

PMID:
10772705
9.

Reduced provirus burden and enhanced humoral immune function in AZT-treated SCID-feline mice inoculated with feline immunodeficiency virus.

Johnson CM, Selleseth DW, Ellis MN, Childers TA, Tompkins MB, Tompkins WA.

Vet Immunol Immunopathol. 1995 May;46(1-2):169-80.

PMID:
7618256
10.

Phosphatidylazidothymidine and phosphatidyl-ddC: assessment of uptake in mouse lymphoid tissues and antiviral activities in human immunodeficiency virus-infected cells and in Rauscher leukemia virus-infected mice.

Hostetler KY, Richman DD, Sridhar CN, Felgner PL, Felgner J, Ricci J, Gardner MF, Selleseth DW, Ellis MN.

Antimicrob Agents Chemother. 1994 Dec;38(12):2792-7.

11.

Feline lymphoid tissues engrafted into scid mice maintain morphologic structure and produce feline immunoglobulin.

Johnson CM, Selleseth DW, Ellis MN, Childers TA, Tompkins MB, Tompkins WA.

Lab Anim Sci. 1994 Aug;44(4):313-8.

PMID:
7983840
12.

Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model.

Condreay LD, Jansen RW, Powdrill TF, Johnson LC, Selleseth DW, Paff MT, Daluge SM, Painter GR, Furman PA, Ellis MN, et al.

Antimicrob Agents Chemother. 1994 Mar;38(3):616-9.

13.

Orofacial infection of athymic mice with defined mixtures of acyclovir-susceptible and acyclovir-resistant herpes simplex virus type 1.

Ellis MN, Waters R, Hill EL, Lobe DC, Selleseth DW, Barry DW.

Antimicrob Agents Chemother. 1989 Mar;33(3):304-10.

Supplemental Content

Loading ...
Support Center